Literature DB >> 466340

Remission of a syndrome indistinguishable from motor neurone disease after resection of bronchial carcinoma.

D M Mitchell, S A Olczak.   

Abstract

Entities:  

Mesh：

Year:  1979        PMID： 466340      PMCID： PMC1595903          DOI： 10.1136/bmj.2.6183.176-a

Source DB:  PubMed          Journal:  Br Med J        ISSN： 0007-1447


× No keyword cloud information.
  3 in total

1.  Carcinomatous neuromyopathy. Its incidence in patients with carcinoma of the lung and carcinoma of the breast.

Authors:  P B CROFT; M WILKINSON
Journal:  Lancet       Date:  1963-01-26       Impact factor: 79.321

2.  Motor neurone disease as a manifestation of neoplasm (with a note on the course of classical motor neurone disease).

Authors:  L Brain; P B Croft; M Wilkinson
Journal:  Brain       Date:  1965-09       Impact factor: 13.501

3.  The epidemiology of amyotrophic lateral sclerosis in Finland. A study based on the death certificates of 421 patients.

Authors:  M Jokelainen
Journal:  J Neurol Sci       Date:  1976-09       Impact factor: 3.181
  3 in total
  8 in total

Review 1.  A review of the therapy of paraneoplastic neurologic syndromes.

Authors:  A Das; F H Hochberg; S McNelis
Journal:  J Neurooncol       Date:  1999-01       Impact factor: 4.130

2.  Adult onset motor neuron disease: worldwide mortality, incidence and distribution since 1950.

Authors:  A M Chancellor; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-12       Impact factor: 10.154

3.  Absence of paraneoplastic antineuronal antibodies in sera of 145 patients with motor neuron disease.

Authors:  Oliver Stich; Barbara Kleer; Sebastian Rauer
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-02-21       Impact factor: 10.154

4.  Peripheral nerve function in patients with bronchial carcinoma. Comparison with matched controls and effects of treatment.

Authors:  J A Lenman; A M Fleming; M A Robertson; R J Abbott; M D Clee; I F Ferguson; D S Wright
Journal:  J Neurol Neurosurg Psychiatry       Date:  1981-01       Impact factor: 10.154

5.  Neurological signs in relation to cancer in patients with asbestosis.

Authors:  J Juntunen; P Oksa; E Pukkala; P Laippala
Journal:  Occup Environ Med       Date:  1997-10       Impact factor: 4.402

6.  Population-based risks for cancer in patients with ALS.

Authors:  Summer B Gibson; Diana Abbott; James M Farnham; Khanh K Thai; Hailey McLean; Karla P Figueroa; Mark B Bromberg; Stefan M Pulst; Lisa Cannon-Albright
Journal:  Neurology       Date:  2016-05-11       Impact factor: 9.910

Review 7.  Risk factors for amyotrophic lateral sclerosis.

Authors:  Caroline Ingre; Per M Roos; Fredrik Piehl; Freya Kamel; Fang Fang
Journal:  Clin Epidemiol       Date:  2015-02-12       Impact factor: 4.790

8.  Amyotrophic lateral sclerosis and cancer: a register-based study in Sweden.

Authors:  Fang Fang; Ammar Al-Chalabi; Lars-Olof Ronnevi; Martin R Turner; Karin Wirdefeldt; Freya Kamel; Weimin Ye
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2013-03-26       Impact factor: 4.092
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.